Singapore markets close in 6 hours 41 minutes
Straits Times Index
3,108.39 +4.28 (+0.14%) Nikkei
26,098.00 -325.47 (-1.23%) Hang Seng
21,759.10 -93.97 (-0.43%) FTSE 100
7,025.47 -207.18 (-2.86%) BTC-USD
19,879.12 -359.52 (-1.78%) CMC Crypto 200
429.71 -10.32 (-2.35%)
Takeda Pharmaceutical Company Limited (TAK)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 42.73B |
| Enterprise value | 68.14B |
| Trailing P/E | 26.39 |
| Forward P/E | 9.95 |
| PEG Ratio (5 yr expected) | 0.51 |
| Price/sales (ttm) | 1.70 |
| Price/book (mrq) | 1.05 |
| Enterprise value/revenue | 0.02 |
| Enterprise value/EBITDA | 0.07 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.90 |
| 52-week change 3 | -15.27% |
| S&P500 52-week change 3 | -12.23% |
| 52-week high 3 | 17.31 |
| 52-week low 3 | 13.05 |
| 50-day moving average 3 | 14.14 |
| 200-day moving average 3 | 14.47 |
Share statistics
| Avg vol (3-month) 3 | 2.65M |
| Avg vol (10-day) 3 | 2.61M |
| Shares outstanding 5 | 3.11B |
| Implied shares outstanding 6 | N/A |
| Float 8 | 3.06B |
| % held by insiders 1 | 0.01% |
| % held by institutions 1 | 1.86% |
| Shares short (14 Jun 2022) 4 | 4.06M |
| Short ratio (14 Jun 2022) 4 | 1.5 |
| Short % of float (14 Jun 2022) 4 | N/A |
| Short % of shares outstanding (14 Jun 2022) 4 | 0.13% |
| Shares short (prior month 12 May 2022) 4 | 5.3M |
Dividends & splits
| Forward annual dividend rate 4 | 0.8 |
| Forward annual dividend yield 4 | 5.67% |
| Trailing annual dividend rate 3 | 180.00 |
| Trailing annual dividend yield 3 | 1,277.50% |
| 5-year average dividend yield 4 | 4.36 |
| Payout ratio 4 | 60.92% |
| Dividend date 3 | 14 Dec 2009 |
| Ex-dividend date 4 | 28 Sept 2021 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in JPY.Fiscal year
| Fiscal year ends | 30 Mar 2022 |
| Most-recent quarter (mrq) | 30 Mar 2022 |
Profitability
| Profit margin | 6.45% |
| Operating margin (ttm) | 16.80% |
Management effectiveness
| Return on assets (ttm) | 2.87% |
| Return on equity (ttm) | 4.24% |
Income statement
| Revenue (ttm) | 3.57T |
| Revenue per share (ttm) | 1,141.35 |
| Quarterly revenue growth (yoy) | 13.40% |
| Gross profit (ttm) | 2.44T |
| EBITDA | 1.11T |
| Net income avi to common (ttm) | 230.06B |
| Diluted EPS (ttm) | 0.54 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 849.7B |
| Total cash per share (mrq) | 274.03 |
| Total debt (mrq) | 4.81T |
| Total debt/equity (mrq) | 84.64 |
| Current ratio (mrq) | 1.21 |
| Book value per share (mrq) | 1,832.81 |
Cash flow statement
| Operating cash flow (ttm) | 1.12T |
| Levered free cash flow (ttm) | 928.76B |
© 2022 Yahoo. All rights reserved.
